MeSH Browser

MeSH Supplementary: durvalumab
Unique ID: C000613593
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000613593
Entry Term(s): Imfinzi; MEDI-4736; MEDI4736
Pharm Action: Antineoplastic Agents, Immunological
Registry Numbers: 28X28X9OKV; 0
Heading Mapped to: *Antibodies, Monoclonal
Frequency: 513
Note: an IgG1 that targets programmed cell death 1 ligand 1 (PD-L1); enhances the immune response to tumor cells and is used for the treatment of locally advanced or metastatic urothelial carcinoma
Source: Lancet Oncol. 2016 Mar;17(3):299-308.
Date of Entry: 2017/01/22
Revision Date: 2019/10/31

durvalumab MeSH Supplementary Concept Data 2025